Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gishel New

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Neurosurgery|May 15, 2002
Multicenter study of the feasibility and safety of using the memotherm carotid arterial stent for extracranial carotid artery stenosisAdnan I Qureshi, M Fareed K Suri, Gishel New, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 3, 2002
Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary modelGishel New, Jeffrey W Moses, Gary S Roubin, et al.
The American Journal of Cardiology|September 17, 2011
Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stentsWilliam McLeish Wilson, Nick Andrianopoulos, David Clark, et al.
Epidemiology (Cambridge, Mass.)|June 20, 2002
New-device angioplasty in women: clinical outcome and predictors in a 7,372-patient registryAlexandra J Lansky, Roxana Mehran, George Dangas, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 22, 2008
Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stentsJames A Shaw, Nick Andrianopoulos, Stephen Duffy, et al.
International Journal of Cardiology|August 19, 2008
Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registryBryan P Yan, Andrew E Ajani, Gishel New, et al.
The American Journal of Cardiology|April 11, 2003
Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteriesDale T Ashby, Roxana Mehran, Eve A Aymong, et al.
The American Journal of Cardiology|December 20, 2011
Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary interventionWilliam Chan, Andrew E Ajani, David J Clark, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 30, 2007
An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registryBryan P Yan, Ronen Gurvitch, Stephen J Duffy, et al.
The American Journal of Cardiology|December 20, 2011
Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary interventionWilliam Chan, Dion Stub, David J Clark, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Neurosurgery|May 15, 2002
Multicenter study of the feasibility and safety of using the memotherm carotid arterial stent for extracranial carotid artery stenosisAdnan I Qureshi, M Fareed K Suri, Gishel New, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 3, 2002
Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary modelGishel New, Jeffrey W Moses, Gary S Roubin, et al.
The American Journal of Cardiology|September 17, 2011
Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stentsWilliam McLeish Wilson, Nick Andrianopoulos, David Clark, et al.
Epidemiology (Cambridge, Mass.)|June 20, 2002
New-device angioplasty in women: clinical outcome and predictors in a 7,372-patient registryAlexandra J Lansky, Roxana Mehran, George Dangas, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 22, 2008
Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stentsJames A Shaw, Nick Andrianopoulos, Stephen Duffy, et al.
International Journal of Cardiology|August 19, 2008
Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registryBryan P Yan, Andrew E Ajani, Gishel New, et al.
The American Journal of Cardiology|April 11, 2003
Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteriesDale T Ashby, Roxana Mehran, Eve A Aymong, et al.
The American Journal of Cardiology|December 20, 2011
Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary interventionWilliam Chan, Andrew E Ajani, David J Clark, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 30, 2007
An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registryBryan P Yan, Ronen Gurvitch, Stephen J Duffy, et al.
The American Journal of Cardiology|December 20, 2011
Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary interventionWilliam Chan, Dion Stub, David J Clark, et al.
Pageof 4